130 related articles for article (PubMed ID: 1576489)
21. Effects of clodronate in severe hyperparathyroid bone disease in chronic renal failure.
Hamdy NA; McCloskey EV; Brown CB; Kanis JA
Nephron; 1990; 56(1):6-12. PubMed ID: 2146521
[TBL] [Abstract][Full Text] [Related]
22. Influence of PTH assay methodology on differential diagnosis of renal bone disease.
Reichel H; Esser A; Roth HJ; Schmidt-Gayk H
Nephrol Dial Transplant; 2003 Apr; 18(4):759-68. PubMed ID: 12637646
[TBL] [Abstract][Full Text] [Related]
23. [Radiologic study of renal osteodystrophy].
Bilbao JI; Villaró J; San Julián M; Purroy A
Rev Med Univ Navarra; 1982 Dec; 26(4):229-37. PubMed ID: 7182894
[No Abstract] [Full Text] [Related]
24. Two-site immunoradiometric intact parathyroid hormone assay versus C-terminal parathyroid hormone in predicting osteodystrophic bone lesions in predialysis chronic renal failure.
Coen G; Mazzaferro S; Ballanti P; Bonucci E; Cinotti GA; Fondi G; Manni M; Pasquali M; Perruzza I; Sardella D
J Lab Clin Med; 1993 Jul; 122(1):103-9. PubMed ID: 8320484
[TBL] [Abstract][Full Text] [Related]
25. Long term results of subtotal parathyroidectomy in patients with end-stage renal disease.
Kim HC; Cheigh JS; David DS; Stubenbord W; Sullivan J; Rubin AL; Stenzel KH
Am Surg; 1994 Sep; 60(9):641-9. PubMed ID: 8060033
[TBL] [Abstract][Full Text] [Related]
26. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
Ghazali A; Fardellone P; Pruna A; Atik A; Achard JM; Oprisiu R; Brazier M; Remond A; Morinière P; Garabedian M; Eastwood J; Fournier A
Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266
[TBL] [Abstract][Full Text] [Related]
27. Evidence for interrupted bone resorption in human iliac cancellous bone.
Croucher PI; Gilks WR; Compston JE
J Bone Miner Res; 1995 Oct; 10(10):1537-43. PubMed ID: 8686510
[TBL] [Abstract][Full Text] [Related]
28. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
Coen G; Ballanti P; Balducci A; Grandi F; Manni M; Mantella D; Pierantozzi A; Ruggeri M; Sardella D; Sorbo G; Bonucci E
Am J Kidney Dis; 2006 Jul; 48(1):106-13. PubMed ID: 16797392
[TBL] [Abstract][Full Text] [Related]
29. Automatic-interactive measurement of resorption cavities in transiliac bone biopsies and correlation with deoxypyridinoline.
Roux JP; Arlot ME; Gineyts E; Meunier PJ; Delmas PD
Bone; 1995 Aug; 17(2):153-6. PubMed ID: 8554923
[TBL] [Abstract][Full Text] [Related]
30. A structural approach to renal bone disease.
Parfitt AM
J Bone Miner Res; 1998 Aug; 13(8):1213-20. PubMed ID: 9718188
[No Abstract] [Full Text] [Related]
31. [A case of hyperparathyroid bone disease and the review of renal osteodystrophy].
Soejima M; Takasugi M; Kuroiwa A; Okajima T; Zeze F
Fukuoka Igaku Zasshi; 1992 Jul; 83(7):319-21. PubMed ID: 1398425
[TBL] [Abstract][Full Text] [Related]
32. Surgical management of secondary hyperparathyroidism.
Gordon HE; Coburn JW; Passaro E
Arch Surg; 1972 Apr; 104(4):520-6. PubMed ID: 5013791
[No Abstract] [Full Text] [Related]
33. Early radiographic manifestations of secondary hyperparathyroidism associated with chronic renal disease.
Jensen PS; Kliger AS
Radiology; 1977 Dec; 125(3):645-52. PubMed ID: 928688
[TBL] [Abstract][Full Text] [Related]
34. Renal bone disease--what is it and why does it happen?
Feest TG; Ward MK; Ellis HA; Conceicao S; Pierides AM; Aird E; Simpson W; Cook DB; Kerr DN
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():19s-23s. PubMed ID: 342144
[No Abstract] [Full Text] [Related]
35. Primary bone oxalosis: the roles of oxalate deposits and renal osteodystrophy.
Benhamou CL; Pierre D; Geslin N; Viala JF; Maitre F; Chavassieux P; Edouard C; Meunier PJ
Bone; 1987; 8(2):59-64. PubMed ID: 3593609
[TBL] [Abstract][Full Text] [Related]
36. Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients.
Pizzarelli F; Zoccali C; Ciccarelli C; Maggiore Q; Bonucci E; Ballanti P
Nephron; 1982; 32(1):93-4. PubMed ID: 7177287
[TBL] [Abstract][Full Text] [Related]
37. Microscopic bone pathology in two cases of surgically treated secondary hyperparathyroidism. Report of a distinct skeletal lesion.
Vigorita VJ; Einhorn TA; Phelps KR
Am J Surg Pathol; 1987 Mar; 11(3):205-9. PubMed ID: 3826480
[TBL] [Abstract][Full Text] [Related]
38. Catabolic and anabolic phases of osteodystrophy in aged rats.
Roach HI; Clarke NM; Langley-Evans S; Cooper C
J Bone Miner Metab; 2003; 21(5):299-306. PubMed ID: 12928831
[TBL] [Abstract][Full Text] [Related]
39. Surgically induced uremia in rats. II: Osseous PTH-susceptible signaling systems as predictors of bone resorption.
Jablonski G; Danielsen CC; Mosekilde L; Gordeladze JO
Calcif Tissue Int; 1994 Oct; 55(4):281-7. PubMed ID: 7820779
[TBL] [Abstract][Full Text] [Related]
40. Bone disease in renal failure. Clinical and histomorphometric studies.
Nilsson P
Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
